Drug delivery device and method

1. A method of using an implantable drug delivery device to deliver a drug to a living body, the implantable drug delivery device having a housing with at least one opening, a reservoir within the housing adapted to contain the drug, a temporary seal closing the at least one opening of the housing, and a heating element in thermal contact with the temporary seal, wherein the heating element is a tubular shaped ferrous heating element incorporated into the housing so as to be within the reservoir and in thermal contact with the temporary seal, the heating element generating heat in response to an oscillating magnetic field to at least partially melt the temporary seal and release the drug within the reservoir through the at least one opening of the housing, the method comprising:

placing the drug in the reservoir of the housing;

implanting the implantable drug delivery device in the living body; and

energizing the heating element in response to a reaction of the living body, the energizing step comprising generating the heat with the heating element in response to electrical current supplied to the heating element via application of the oscillating magnetic field to at least partially melt the temporary seal and release the drug within the reservoir through the at least one opening of the housing, the heating element sufficiently melting the temporary seal to release the drug into the living body through the at least one opening in the housing.

2. The method of claim 1 , wherein the reaction of the living body is a physiological reaction to an opioid overdose.

3. The method of claim 2 , wherein the physiological reaction is a rise in body temperature.

4. The method of claim 1 , wherein the drug is naloxone, epinephrine, or naltrexone.

5. The method of claim 1 , wherein the temporary seal is formed of a biocompatible cross linked polymer.

6. The method of claim 1 , further comprising automatically or manually triggering the heating element to generate the heat in response to an overdose detected in the living body.

7. The method of claim 1 , wherein the implanting step comprises subcutaneously implanting the implantable drug delivery device.

8. The method of claim 1 , wherein the reaction of the living body is to an opioid overdose and the drug includes an anti overdose drug that treats the opioid overdose.

9. The method of claim 1 , wherein the drug is contained within the reservoir under pressure and is forcibly ejected from the reservoir once the temporary seal has at least partially melted.